Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPLENDOR: Pioglitazone in T2DM with Vascular Complications
NCT00770835Phase 4Completed
- Sponsor
- Takeda
- Start
- Mar 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Mar 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00770835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770835.